#nbix

[fmarkets]

Neurocrine Biosciences Inc Tops Charts with Remarkable Financial Growth in 2023 https://csimarket.com/stocks/news.php?code=NBIX&date=2024-02-10120624&utm_source=dlvr.it&utm_medium=tumblr

[reportwire]

Neurocrine Biosciences (NBIX) – Research Analysts’ Recent Ratings Updates

Neurocrine Biosciences (NBIX) – Research Analysts’ Recent Ratings Updates

Several analysts have recently updated their ratings and price targets for Neurocrine Biosciences (NASDAQ: NBIX): 12/8/2021 – Neurocrine Biosciences had its price target raised by analysts at Oppenheimer Holdings Inc. from $140.00 to $154.00. They now have an “outperform” rating on the stock. 12/8/2021 – Neurocrine Biosciences was upgraded by analysts at Zacks Investment Research from a “sell”…

View On WordPress

[moneyhealthfinance-blog]

Neurocrine Biosciences Inc (NBIX) Q1 2019 Earnings Call Transcript Image source The Motley Fool Neurocrine Biosciences Inc NASDAQ NBIX Q1 160 2019 Earnings Call April 29 2019 4 30 p m ET Contents Prepared Remarks Questions and Answers Call Participants Prepared Remarks... Latest Articles in

[ustribunenews-blog]

Neurocrine Biosciences, Inc. (Nasdaq:NBIX) Sets 52 Week High Bar Of $126.28

Neurocrine Biosciences, Inc. (Nasdaq:NBIX) Sets 52 Week High Bar Of $126.28

Neurocrine Biosciences, Inc. (Nasdaq:NBIX)

September 4th, 2018

Amidst falling markets Neurocrine Biosciences, Inc. closed Monday up 2.36%, a $2.90 increase to close on $125.85. Furthermore it hit a new 52 week high of $126.28. The stock continues to trade well at 125% of its 52 week low of $55.88. (more…)

View On WordPress

[ustribunenews-blog]

Hitting 52 Week High, Neurocrine Biosciences, Inc. (Nasdaq:NBIX) Finishes At $122.10

Hitting 52 Week High, Neurocrine Biosciences, Inc. (Nasdaq:NBIX) Finishes At $122.10

Neurocrine Biosciences, Inc. (Nasdaq:NBIX)

August 30th, 2018

Amidst falling markets Neurocrine Biosciences, Inc. closed Thursday up 0.36%, a $0.44 increase to close on $122.10. Furthermore it hit a new 52 week high of $123.01. The stock continues to trade well at 134% of its 52 week low of $52.22. (more…)

View On WordPress

[ustribunenews-blog]

Setting 52 Week High, Neurocrine Biosciences, Inc. (Nasdaq:NBIX) Close At $121.11

Setting 52 Week High, Neurocrine Biosciences, Inc. (Nasdaq:NBIX) Close At $121.11

Neurocrine Biosciences, Inc. (Nasdaq:NBIX)

August 27th, 2018

With markets going up Neurocrine Biosciences, Inc. went up $2.40 Monday, a 2.02% jump, closing at $121.11. Furthermore it hit a new 52 week high of $121.38. The stock continues to trade well at 136% of its 52 week low of $51.42. (more…)

View On WordPress

[ustribunenews-blog]

(Nasdaq:NBIX) Neurocrine Biosciences, Inc. Breaks 52 Week High Bar Of $120.90

(Nasdaq:NBIX) Neurocrine Biosciences, Inc. Breaks 52 Week High Bar Of $120.90

Neurocrine Biosciences, Inc. (Nasdaq:NBIX)

August 9th, 2018

Neurocrine Biosciences, Inc. closed the day up $2.50 Saturday, a 2.14% increase, closing at $119.36. Furthermore it hit a new 52 week high of $120.90. The stock continues to trade well at 135% of its 52 week low of $50.88. (more…)

View On WordPress

[ustribunenews-blog]

Hitting 52 Week High, Neurocrine Biosciences, Inc. (Nasdaq:NBIX) Ends The Day At $115.69

Hitting 52 Week High, Neurocrine Biosciences, Inc. (Nasdaq:NBIX) Ends The Day At $115.69

Neurocrine Biosciences, Inc. (Nasdaq:NBIX)

August 2nd, 2018

Neurocrine Biosciences, Inc. finished up $2.14 Thursday, up 1.88%, closing at $115.69. Furthermore it hit a new 52 week high of $117.91. The stock continues to trade well at 145% of its 52 week low of $47.24. In addition to finishing higher, trading volumes were solid at 221% of normal which can indicate investors see opportunities. (…

View On WordPress